Cornea Disease
Endothelial keratoplasty, dystrophy management, and graft-survival research — evaluating therapies for Fuchs’ dystrophy and corneal transplantation.
Cascade Medical Research Institute (CMRI) is an independent, physician-founded institute dedicated to advancing eye care through innovative clinical research, cutting-edge clinical trials, and scientific discovery.
CMRI was created with a mission to accelerate the development of new treatments, expand patient access to emerging therapies, and contribute meaningful knowledge to the field of ophthalmology.
At CMRI, we conduct both industry-sponsored and investigator-led clinical trials. Our research programs focus on evaluating novel medical and surgical therapies that have the potential to improve outcomes and redefine standards of care. In addition to clinical trials, our physician-scientists lead independent research initiatives that address important clinical questions and advance the field of ophthalmology.
With specialized expertise in cornea and retinal diseases, CMRI is committed to advancing evidence-based medicine through rigorous research, scientific collaboration, and a patient-centered approach.
Endothelial keratoplasty, dystrophy management, and graft-survival research — evaluating therapies for Fuchs’ dystrophy and corneal transplantation.
AMD therapeutics, gene-therapy delivery, and diabetic retinopathy trials — advancing care for macular degeneration and diabetic macular edema.
Read about our past and current studies.
A list of recent publications from the investigators of Cascade Medical Research Institute.
Subscribe to our quarterly newsletter.